Maki Nagata

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.

Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.

Journal: Anticancer research

Published: March 17, 2026

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

Journal: The Prostate

Published: February 03, 2026

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Journal: BJU international

Published: November 13, 2025

Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Journal: Japanese journal of clinical oncology

Published: March 26, 2025

Reevaluating the Therapeutic Role of Pelvic Lymph Node Dissection in Robot-Assisted Radical Prostatectomy.

Reevaluating the Therapeutic Role of Pelvic Lymph Node Dissection in Robot-Assisted Radical Prostatectomy.

Journal: Asian journal of endoscopic surgery

Published: February 23, 2025

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer.

Clinical significance of primary tumor progression in metastatic hormone-sensitive prostate cancer.

Journal: Prostate international

Published: October 15, 2024

Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.

Characterization of PSA dynamics and oncological outcomes in patients with metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors.

Journal: International journal of clinical oncology

Published: September 18, 2024

Clinical remission of mild-to-moderate asthma: Rates, contributing factors, and stability.

Clinical remission of mild-to-moderate asthma: Rates, contributing factors, and stability.

Journal: The journal of allergy and clinical immunology. Global

Published: August 13, 2024

Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon.

Novel nerve-sparing robot-assisted radical prostatectomy with endopelvic fascia preservation and long-term outcomes for a single surgeon.

Journal: Scientific reports

Published: November 25, 2023

Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.

Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 06, 2022

Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas.

Feasibility of single-port laparoscopic partial adrenalectomy with selective adrenal venous sampling and high-resolution ultrasound for unilateral aldosterone-producing adenomas.

Journal: Surgery

Published: October 23, 2022

Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis.

Pathological complete response of plasmacytoid variant bladder cancer to pembrolizumab following genomic analysis.

Journal: IJU case reports

Published: March 14, 2022

Showing 1-12 of 23

Last Updated: 09/26/2026